Yabao Pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency
Yabao Pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Yabao Pharmaceutical Group Co Ltd (600351) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥129.49 Million ≈ $18.95 Million USD) by net assets (CN¥2.76 Billion ≈ $403.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Yabao Pharmaceutical Group Co Ltd (2001–2024)
Cash flow conversion efficiency of Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. This chart illustrates how Yabao Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Yabao Pharmaceutical Group Co Ltd stock price for real-time trading data and today's change.
Yabao Pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained
Yabao Pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Yabao Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yabao Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see Yabao Pharmaceutical Group Co Ltd (600351) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Legacy Housing Corp
NASDAQ:LEGH
|
0.043x |
|
Foshan Golden Milky Way Intelligent Equipment Co Ltd
SHE:300619
|
0.170x |
|
Pilkington Deutschland AG
HM:FDD
|
N/A |
|
Yixin Group Limited
F:1YX
|
-0.057x |
|
Atlantic China Welding Consumables Inc
SHG:600558
|
0.010x |
|
Beijing Qianjing Landscape Co
SHG:603778
|
0.347x |
|
KSL Holdings Bhd
KLSE:5038
|
-0.011x |
|
Vital Energy Inc.
NYSE:VTLE
|
0.163x |
Annual Cash Flow Conversion Efficiency for Yabao Pharmaceutical Group Co Ltd (2001–2024)
The table below shows the annual cash flow conversion efficiency of Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. Review Yabao Pharmaceutical Group Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.89 Billion ≈ $423.62 Million |
CN¥471.69 Million ≈ $69.02 Million |
0.163x | -1.98% |
| 2023-12-31 | CN¥2.99 Billion ≈ $438.01 Million |
CN¥497.55 Million ≈ $72.81 Million |
0.166x | +8.54% |
| 2022-12-31 | CN¥3.01 Billion ≈ $439.97 Million |
CN¥460.46 Million ≈ $67.38 Million |
0.153x | +3.74% |
| 2021-12-31 | CN¥2.96 Billion ≈ $433.67 Million |
CN¥437.50 Million ≈ $64.02 Million |
0.148x | +9.21% |
| 2020-12-31 | CN¥2.82 Billion ≈ $412.41 Million |
CN¥380.96 Million ≈ $55.75 Million |
0.135x | -13.38% |
| 2019-12-31 | CN¥2.72 Billion ≈ $398.67 Million |
CN¥425.17 Million ≈ $62.22 Million |
0.156x | +10.21% |
| 2018-12-31 | CN¥3.01 Billion ≈ $440.86 Million |
CN¥426.60 Million ≈ $62.43 Million |
0.142x | +155.17% |
| 2017-12-31 | CN¥2.91 Billion ≈ $426.47 Million |
CN¥161.73 Million ≈ $23.67 Million |
0.055x | -2.85% |
| 2016-12-31 | CN¥2.73 Billion ≈ $399.54 Million |
CN¥155.95 Million ≈ $22.82 Million |
0.057x | +6.62% |
| 2015-12-31 | CN¥2.68 Billion ≈ $391.88 Million |
CN¥143.47 Million ≈ $20.99 Million |
0.054x | -45.42% |
| 2014-12-31 | CN¥1.82 Billion ≈ $266.31 Million |
CN¥178.63 Million ≈ $26.14 Million |
0.098x | +193.10% |
| 2013-12-31 | CN¥1.70 Billion ≈ $248.21 Million |
CN¥56.80 Million ≈ $8.31 Million |
0.033x | +155.92% |
| 2012-12-31 | CN¥1.62 Billion ≈ $236.39 Million |
CN¥-96.73 Million ≈ $-14.15 Million |
-0.060x | -270.37% |
| 2011-12-31 | CN¥1.16 Billion ≈ $169.56 Million |
CN¥40.73 Million ≈ $5.96 Million |
0.035x | +89.80% |
| 2010-12-31 | CN¥1.00 Billion ≈ $146.71 Million |
CN¥18.57 Million ≈ $2.72 Million |
0.019x | -95.48% |
| 2009-12-31 | CN¥899.55 Million ≈ $131.63 Million |
CN¥368.56 Million ≈ $53.93 Million |
0.410x | +230.61% |
| 2008-12-31 | CN¥830.32 Million ≈ $121.50 Million |
CN¥102.90 Million ≈ $15.06 Million |
0.124x | -55.43% |
| 2007-12-31 | CN¥380.08 Million ≈ $55.62 Million |
CN¥105.69 Million ≈ $15.47 Million |
0.278x | +702.54% |
| 2006-12-31 | CN¥334.54 Million ≈ $48.95 Million |
CN¥11.59 Million ≈ $1.70 Million |
0.035x | -53.49% |
| 2005-12-31 | CN¥354.37 Million ≈ $51.86 Million |
CN¥26.40 Million ≈ $3.86 Million |
0.074x | -68.41% |
| 2004-12-31 | CN¥338.16 Million ≈ $49.48 Million |
CN¥79.73 Million ≈ $11.67 Million |
0.236x | +879.94% |
| 2003-12-31 | CN¥318.26 Million ≈ $46.57 Million |
CN¥-9.62 Million ≈ $-1.41 Million |
-0.030x | -134.57% |
| 2002-12-31 | CN¥277.81 Million ≈ $40.65 Million |
CN¥24.29 Million ≈ $3.55 Million |
0.087x | -65.96% |
| 2001-12-31 | CN¥91.84 Million ≈ $13.44 Million |
CN¥23.59 Million ≈ $3.45 Million |
0.257x | -- |
About Yabao Pharmaceutical Group Co Ltd
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 a… Read more